Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply
- PMID: 32101678
- DOI: 10.1056/NEJMc1915676
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply
Comment on
-
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.N Engl J Med. 2020 Feb 27;382(9):876. doi: 10.1056/NEJMc1915676. N Engl J Med. 2020. PMID: 32101675 No abstract available.
-
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.N Engl J Med. 2020 Feb 27;382(9):876. doi: 10.1056/NEJMc1915676. N Engl J Med. 2020. PMID: 32101676 No abstract available.
-
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.N Engl J Med. 2020 Feb 27;382(9):876-877. doi: 10.1056/NEJMc1915676. N Engl J Med. 2020. PMID: 32101677 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials